大博医疗：预计2025年实现净利润约5.8亿元至6.1亿元，业绩增长主因归功于坚持产品创新及国际化发展战略

Core Viewpoint - The company, Dabo Medical, anticipates a significant increase in net profit for the fiscal year 2025, projecting a range of approximately 580 million to 610 million yuan, representing a year-on-year growth of about 62.55% to 70.96% compared to 357 million yuan in the previous year [1] Financial Performance - The expected basic earnings per share for 2025 are projected to be between 1.43 yuan and 1.5 yuan, which shows a notable increase from 0.86 yuan per share in the same period last year [1] Growth Drivers - The company attributes its performance growth to a focus on its core business, commitment to product innovation, technical services, and international development strategies, which have driven the continuous and stable development of its various business segments [1]